2018
DOI: 10.1016/j.oraloncology.2018.02.014
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
46
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 59 publications
(50 citation statements)
references
References 46 publications
2
46
0
2
Order By: Relevance
“…Activating mutations of PIK3CA have been found in approximately 20% of HNSCC, and increase in PIK3CA copy number and/or overexpression is present in up to 40% of the cases [3]. Overexpression of the PIK3CA gene is a poor prognosis factor in HNSCC and is associated with the activation of YAP [24]. In contrast to other tumors, mutations in EGFR are not frequent in HNSCC (≤5%) [3].…”
Section: Molecular Alterations In Hnsccmentioning
confidence: 99%
See 1 more Smart Citation
“…Activating mutations of PIK3CA have been found in approximately 20% of HNSCC, and increase in PIK3CA copy number and/or overexpression is present in up to 40% of the cases [3]. Overexpression of the PIK3CA gene is a poor prognosis factor in HNSCC and is associated with the activation of YAP [24]. In contrast to other tumors, mutations in EGFR are not frequent in HNSCC (≤5%) [3].…”
Section: Molecular Alterations In Hnsccmentioning
confidence: 99%
“…Additionally, two upstream regulators of this pathway are frequently altered in HNSCC, namely FAT1 and PIK3CA. Inactivation of FAT1 (deletion, truncating mutations) or activation of PIK3CA (overexpression) are associated with YAP-dependent transcriptional activation in HNSCC [24,27]. The precise molecular mechanisms that contribute to tumor development in the context of FAT1 functional loss or PIK3CA overexpression are not fully understood (Figure 2).…”
Section: The Hippo-yap Pathway In Hnsccmentioning
confidence: 99%
“…[ 169 ] Recent evidence suggests that PI3K‐Akt signaling also inhibits the Hippo pathway to promote YAP/TAZ activation to drive cell proliferation and malignancy. [ 99,115,170‐178 ] Importantly, further work is necessary to identify the molecular mechanism by which PI3K‐Akt signaling inhibits the Hippo pathway. In addition, while PI3K‐Akt signaling appears necessary to promote YAP/TAZ activation, it is apparently not sufficient, as cells also require mechanical stimulation or other additional inputs to activate YAP/TAZ.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, YAP was also shown to undergo monomethylation by SET1A, which in turn blocks its cytoplasmic export and ultimately promotes tumorigenesis [11]. As part of a crosstalk with other signaling pathways, YAP nuclear localization and activation is induced by PI3 kinase (PI3K) and phosphoinositide-dependent kinase (PDK1), which work in concert by inhibiting the Hippo pathway, leading to poor prognosis in patients [12,13]. While discussed elsewhere, it is important to note that other signaling pathways, including WNT and G protein-coupled signaling, as well as processes like metabolism and mechanotransduction also regulate YAP/TAZ [14].…”
mentioning
confidence: 99%